Katalog der Deutschen Nationalbibliothek

Go to:

Catalogue (Beta)

Knowledge Web

Person
Person

Person

Lutz Frölich (1956-)

Psychiater

Name

Lutz Frölich

Time

1956- (Date of birth and death)

Place

Neumünster (Geburtsort)
Mannheim (Wirkungsort)
Deutschland

Gender

männlich

Academic degree

Prof. Dr. med.

Profession

Psychiater (characteristic profession)

Variant

Lutz Froelich
L. Frölich
L. Froelich
Lutz Frolich

Related

Klinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters (Mannheim)

Further information

Professor für Psychiatrie und Mitarbeiter in der Gerontopsychiatrie der Klinik für Psychiatrie und Psychotherapie am Zentralinstitut für Seelische Gesundheit Mannheim und Professor für Psychotherapie an der Medizinischen Fakultät Mannheim der Universität Heidelberg

Record type

Person

GND-Identifier

1028327099

Record ID

1028327099

Involved in

show all

Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

Stationsäquivalente Behandlung (StäB) gerontopsychiatrischer Patienten in einer deutschen Großstadt – Eine Beobachtungsstudie

Differential psychological treatment effects in patients with late-life depression and a history of childhood maltreatment

Geriatrie : Das gesamte Spektrum der Altersmedizin für Klinik und Praxis

Geriatrie : Das gesamte Spektrum der Altersmedizin für Klinik und Praxis

Perceived physical health and cognitive behavioral therapy vs supportive psychotherapy outcomes in adults with late-life depression : : a secondary analysis of a randomized clinical trial

Lecanemab: Appropriate Use Recommendations — A Commentary from a European Perspective

Cognitive Behavioral Therapy for Late-Life Depression (CBTlate): Results of a Multicenter, Randomized, Observer-Blinded, Controlled Trial

Cognitive behavioral therapy for late-life depression (CBTlate): results of a multicenter, randomized, observer-blinded, controlled trial

Erratum zu: Leichte kognitive Beeinträchtigung (MCI) in der altersmedizinischen Praxis: Patientenorientierung, Diagnostik, Behandlung und Ethik

Sensory and motor correlates of frailty: dissociation between frailty phenotype and frailty index

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Leichte kognitive Beeinträchtigung (MCI) in der altersmedizinischen Praxis: Patientenorientierung, Diagnostik, Behandlung und Ethik

Erratum zu: Krankheitsmodifizierende Therapieansätze bei Alzheimer-Krankheit

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network

Kosten der Diagnostik kognitiver Störungen in deutschen Gedächtnisambulanzen

A comparison of operational definitions for mild cognitive impairment

Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network

Krankheitsmodifizierende Therapieansätze bei Alzheimer-Krankheit

Promoting neuroplasticity and neuropsychological functioning in frailty through an app-based sensorimotor training: study protocol for a randomized trial

Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments

Gedächtnisambulanzen in Deutschland – strukturell-organisatorische Voraussetzungen und Aufgabenfelder

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

Identification of a cascade of changes in activities of daily living preceding short-term clinical deterioration in mild Alzheimer’s disease dementia via lead-lag analysis

Case report: a giant arachnoid cyst masking Alzheimer’s disease

Medikamentöse Therapie der Alzheimer-Demenz mit Antidementiva

Cognitive behavioural therapy for the treatment of late life depression : : study protocol of a multicentre, randomized, observer-blinded, controlled trial (CBTlate)

Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer’s disease clinical program

ICD-11: Neurokognitive Störungen

Separating symptomatic Alzheimer’s disease from depression based on structural MRI

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia

On the path to 2025: understanding the Alzheimer’s disease continuum

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia

Drug development in Alzheimer’s disease: the path to 2025

Das Kompetenznetz Demenzen : Erfolge und Ausblicke

Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease

Impaired and preserved aspects of feedback learning in aMCI: contributions of structural connectivity

Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study

Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review

Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference

Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study

Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study

Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease

Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment

Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment

Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment

Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in Alzheimer’s disease

Development of a Tool to Identify Patients' Preference for Vitamin K Antagonist or Direct Oral Anticoagulant Therapy

Arzneitherapie für Ältere

Arzneitherapie für Ältere : mit 58 Tabellen

Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment: Design and Cohort Baseline Characteristics of the German Dementia Competence Network

Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer’s Disease in the European Prospective DESCRIPA Study

Venlafaxin-Associated Post-Ictal Asystole during Electroconvulsive Therapy
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal